Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was directly funded by the Australian Government Department of Health Office of Health Protection. Additional support was provided by the National Health and Medical Research Council of Australia through its Centres of Research Excellence (SPECTRUM, GNT1170960) and Investigator Grant Schemes (JMcV Principal Research Fellowship, GNT1117140; FMS Emerging Leader Fellowship, 2021/GNT2010051).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was undertaken as urgent public health action to support COVID-19 pandemic response in Australia. The study used data from the Australian National Notifiable Disease Surveillance System (NNDSS) provided to the Australian Government Department of Health under the National Health Security Agreement for the purposes of national communicable disease surveillance. Data from the NNDSS were supplied after de-identification to the investigator team for the purposes of provision of epidemiological advice to government. Contractual obligations established strict data protection protocols agreed between the University of Melbourne and sub-contractors and the Australian Government Department of Health with oversight and approval for use in supporting pandemic response in Australia and for publication provided by the data custodians represented by the Communicable Diseases Network of Australia. The ethics of the use of these data for these purposes including publication was agreed by the Department of Health with the Communicable Diseases Network of Australia. The study also used routinely collected patient administration data from the New South Wales (NSW) Notifiable Conditions Information Management System (NCIMS). Data was supplied by the NSW Ministry of Health with all records de-identified and securely managed to ensure patient privacy and to ensure study compliance with the National Health and Medical Research Council Ethical Considerations in Quality Assurance and Evaluation Activities. The NSW Public Health Act (2010) allows for such release of data to identify and monitor risk factors for diseases and conditions that have a substantial adverse impact on the population and to improve service delivery. Following review the NSW Ministry of Health determined that this study met that threshold and therefore provided approval for the study to proceed. The project oversight and approval for publication was provided by the NSW Ministry of Health.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes